In HCT116 colorectal cancer cells, there was no additive effect (radiosensitisation) observed in mutant or null p53 variants for either compound; both AH54 and AH63 caused dose-dependent radiosensitising activity in wildtype p53 cells. Here, TP53 is linked to colorectal cancer.